MedTrace Logo

Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy

NCT07741110 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2026-08-03

No results posted yet for this study

Summary

Clinicopathological and genomic data (Next generation sequencing and IHC/CISH) in available tissues were performed in patients with nasopharyngeal carcinoma who participated in a previously conducted randomized phase II study that evaulated induction chemotherapy followed by CCRT with CCRT alone.

Conditions

  • Nasopharyngeal Carcinoma (NPC)

Interventions

GENETIC

Next generation sequencing

Next generation sequencing performed to available paraffin blocks

GENETIC

Immunohistochemistry/CISH

Immunohistochemistry and CISH in all available paraffin blocks

Sponsors & Collaborators

  • Hellenic Cooperative Oncology Group

    lead OTHER

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-01
Primary Completion
2008-02-28
Completion
2008-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07741110 on ClinicalTrials.gov